Investors Aren't Entirely Convinced By TransAct Technologies Incorporated's (NASDAQ:TACT) Revenues

TransAct Technologies Incorporated's (NASDAQ:TACT) price-to-sales (or "P/S") ratio of 1.1x might make it look like a buy right now compared to the Tech industry in the United States, where around half of the companies have P/S ratios above 1.8x and even P/S above 5x are quite common. However, the P/S might be low for a reason and it requires further investigation to determine if it's justified.

View our latest analysis for TransAct Technologies

ps-multiple-vs-industry
NasdaqGM:TACT Price to Sales Ratio vs Industry September 24th 2025
Advertisement

What Does TransAct Technologies' P/S Mean For Shareholders?

TransAct Technologies could be doing better as its revenue has been going backwards lately while most other companies have been seeing positive revenue growth. Perhaps the P/S remains low as investors think the prospects of strong revenue growth aren't on the horizon. If you still like the company, you'd be hoping this isn't the case so that you could potentially pick up some stock while it's out of favour.

Want the full picture on analyst estimates for the company? Then our free report on TransAct Technologies will help you uncover what's on the horizon.

What Are Revenue Growth Metrics Telling Us About The Low P/S?

There's an inherent assumption that a company should underperform the industry for P/S ratios like TransAct Technologies' to be considered reasonable.

Taking a look back first, the company's revenue growth last year wasn't something to get excited about as it posted a disappointing decline of 9.1%. That put a dampener on the good run it was having over the longer-term as its three-year revenue growth is still a noteworthy 8.8% in total. Accordingly, while they would have preferred to keep the run going, shareholders would be roughly satisfied with the medium-term rates of revenue growth.

Looking ahead now, revenue is anticipated to climb by 12% during the coming year according to the sole analyst following the company. Meanwhile, the rest of the industry is forecast to only expand by 7.3%, which is noticeably less attractive.

In light of this, it's peculiar that TransAct Technologies' P/S sits below the majority of other companies. It looks like most investors are not convinced at all that the company can achieve future growth expectations.

What Does TransAct Technologies' P/S Mean For Investors?

Using the price-to-sales ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.

To us, it seems TransAct Technologies currently trades on a significantly depressed P/S given its forecasted revenue growth is higher than the rest of its industry. The reason for this depressed P/S could potentially be found in the risks the market is pricing in. At least price risks look to be very low, but investors seem to think future revenues could see a lot of volatility.

There are also other vital risk factors to consider before investing and we've discovered 2 warning signs for TransAct Technologies that you should be aware of.

If strong companies turning a profit tickle your fancy, then you'll want to check out this free list of interesting companies that trade on a low P/E (but have proven they can grow earnings).

Valuation is complex, but we're here to simplify it.

Discover if TransAct Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

MI
mitchell_lawler
mitchell_lawler

Apple's near record highs, yet the AI crowd still writes it off as a laggard. I think they're misreading the strategy.

Apple's near record highs, yet the AI crowd still writes it off as a laggard. I think they're misreading the strategy. cover
1411
AR
artoflosing
artoflosing

Apple now is a hedge for hyperscalers.

JA
Jake_Merritt
Jake_Merritt

In that case Google is better placed. It owns both the model and the massive distribution.

Mitchell Lawler

Which payment stocks actually get paid?

Which payment stocks actually get paid? cover
Every new payment app was supposed to kill Visa and Mastercard. Instead, they got bigger. So what does that mean for the payment stocks on your radar?
32

About NasdaqGM:TACT

TransAct Technologies

Designs, develops, and markets transaction-based and specialty printers and terminals in the United States and internationally.

Excellent balance sheet and fair value.

Advertisement

Weekly Picks

RI
Rick_Orford
FJET logo
Rick_Orford on Starfighters Space ·

The 1960s Fighter Jet That Could Crack Open a $20 Billion Satellite Market

Fair Value:US$524.2% undervalued
64 users have followed this narrative
4 users have commented on this narrative
11 users have liked this narrative
JO
John_Eric
Emerging Author
MELI logo
John_Eric on MercadoLibre ·

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$7.31k73.4% undervalued
118 users have followed this narrative
3 users have commented on this narrative
17 users have liked this narrative
RC
PYPL logo
rcb9 on PayPal Holdings ·

Ten Percent More Volume, One Percent More Transaction Margin

Fair Value:US$70.8913.0% undervalued
18 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
HE
HedgeY
MU logo
HedgeY on Micron Technology ·

Micron - The Memory Bottleneck Behind the AI Supercycle

Fair Value:US$1.25k27.2% undervalued
49 users have followed this narrative
1 users have commented on this narrative
18 users have liked this narrative

Updated Narratives

RI
RisbergCapital
COLO B logo
RisbergCapital on Coloplast ·

Coloplast: A Rare Entry Point in Quality Healthcare

Fair Value:DKK 73737.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RI
RisbergCapital
HEM logo
RisbergCapital on Hemnet Group ·

Hemnet: Priced As If the Freeze Were Permanent

Fair Value:SEK 17845.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RI
RisbergCapital
TOM logo
RisbergCapital on Tomra Systems ·

TOMRA: a market leader at a discount

Fair Value:NOK 17537.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28025.5% undervalued
348 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9116.1% overvalued
196 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0944.8% undervalued
222 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative

Trending Discussion

HA
HarishPK
EVER logo
HarishPK on EverQuote ·

Feedback welcome!

3
|
0
MA
MRNA logo
Madave on Moderna ·

Aged like wine

2
|
0